Unfettered experimentation driven by pure curiosity is giving way to a debate over whether to establish “no-go” areas of science—such as using new gene-editing technologies to produce engineered babies, giving flu viruses and other pathogens new capabilities, and engineering microbes to produce illegal drugs. Should we establish no-go areas of research? Who decides and who enforces it? What are the risks of not establishing regulations? Do we limit our potential by limiting ourselves?

Speakers:

Barbara Ward-Dagnon, CEO Medicor Research Inc

Adam Pawluch, Clinical Research Coordinator, Medicor Research Inc.

Dr. Farukh Jabeen, Founder and CEO, Avecina MedCann Innovations

Dr. Michael Yeo, Full Professor, Department of Philosophy Laurentian University